Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma is an aggressive non-Hodgkin's lymphoma without a standard therapy for patients who relapse after or are not eligible for salvage autologous stem cell transplantation. In vitro analysis of lymphoma cell lines has shown that everolimus can inhibit cell cycle progres...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Barnes, Jeffrey A., Jacobsen, Eric, Feng, Yang, Freedman, Arnold, Hochberg, Ephraim P., LaCasce, Ann S., Armand, Philippe, Joyce, Robin, Sohani, Aliyah R., Rodig, Scott J., Neuberg, Donna, Fisher, David C., Abramson, Jeremy S.
Format: Artigo
Langue:Inglês
Publié: Ferrata Storti Foundation 2013
Sujets:
Original Articles and Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659994/
https://ncbi.nlm.nih.gov/pubmed/23144193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.075184
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires